Pharmacokinetics of Mitiperstat in Participants With Hepatic Impairment

NCT05751759 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: Mitiperstat

Sponsor

AstraZeneca